Anzeige
Mehr »
Login
Freitag, 12.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
X-Leak: Jetzt der Mega-Meilenstein - Kurseskalation vorprogrammiert?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PS0P | ISIN: US92764N1028 | Ticker-Symbol:
NASDAQ
11.04.24
21:59 Uhr
9,250 US-Dollar
0,000
0,00 %
1-Jahres-Chart
VIR BIOTECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
VIR BIOTECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur VIR BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.02.Vir Biotechnology, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
26.02.Vir Biotechnology, Inc. - 10-K, Annual Report1
23.02.GSK and Vir Terminate Influenza Alliance a Year After Ending Covid-19 R&D Pact8
23.02.Vir Biotechnology, Community Health Systems among healthcare movers2
23.02.GSK, Vir end flu drug alliance, removing key piece of $345M pact7
23.02.Earnings call: Vir Biotechnology outlines future after mixed 2023 results3
22.02.Vir Biotechnology GAAP EPS of -$0.86 beats by $0.15, revenue of $16.79M beats by $10.24M2
22.02.Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results176SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023. "Vir...
► Artikel lesen
21.02.Vir, in midst of restructuring, loses its chief medical officer1
21.02.Earnings Outlook For Vir Biotechnology2
20.02.Vir Biotechnology announces CMO departure, seeks replacement1
20.02.Vir Biotechnology announces Phil Pang will step down as chief medical officer1
20.02.Vir Biotechnology, Inc. - 8-K, Current Report1
29.01.JP Morgan cuts Vir to neutral, cites hepatitis drug franchise concerns7
29.01.US Beam Therapeutics, Lam Research, Vir Biotechnology26
15.01.Vir Biotechnology (VIR) Gains 21.7% in 3 Months: Here's Why5
14.12.23Vir goes Grinch, eliminating 75 posts and shuttering 2 US sites to slow erosion of $1.7B cash pile6
13.12.23Vir Biotechnology to shed 12% of workforce as part of corporate restructuring3
13.12.23Vir Biotechnology To Reduce Workforce By 12%, To Close 2 Research Facilities2
13.12.23Vir Biotechnology to cut about 75 jobs, shut some facilities2
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1